Clinical Trial Update: Losartan for Patients With COVID-19 Requiring Hospitalization [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating losartan for hospitalized COVID-19 patients has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019
• Respiratory Distress Syndrome

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: University of Minnesota | Conditions: Corona Virus Infection, Acute Respiratory Distress Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2022-06-29